ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer
The Breast
◽
10.1016/j.breast.2013.07.037
◽
2013
◽
Vol 22
(5)
◽
pp. 650-656
◽
Cited By ~ 41
Author(s):
Giuseppe Curigliano
◽
Xavier Pivot
◽
Javer Cortés
◽
Anthony Elias
◽
Rossano Cesari
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Study
◽
Standard Of Care
◽
Randomized Phase Ii
◽
Previously Treated
Download Full-text
Related Documents
Cited By
References
Abstract P6-12-02: A Randomized Phase II Study of Sunitinib vs. Standard of Care for Patients with Previously Treated Advanced Triple-Negative Breast Cancer
10.1158/0008-5472.sabcs10-p6-12-02
◽
2010
◽
Cited By ~ 4
Author(s):
G Curigliano
◽
X Pivot
◽
J Cortes
◽
A Elias
◽
R Cesari
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Study
◽
Standard Of Care
◽
Randomized Phase Ii
◽
Previously Treated
Download Full-text
A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
Annals of Oncology
◽
10.1093/annonc/mdz240.111
◽
2019
◽
Vol 30
◽
pp. v97
Author(s):
H.L. McArthur
◽
E.A. Comen
◽
Y. Bryce
◽
S.B. Solomon
◽
J.H.S. Leal
◽
...
Keyword(s):
Breast Cancer
◽
Neoadjuvant Chemotherapy
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Standard Care
◽
Triple Negative
◽
Phase Ii Study
◽
Early Stage
◽
Standard Of Care
◽
Randomized Phase Ii
Download Full-text
Abstract P5-15-15: Phase II study of navelbine plus carboplatin followed by oral navelbine in patients with metastatic/recurrent triple negative breast cancer previously treated with anthracycline and taxane
10.1158/1538-7445.sabcs16-p5-15-15
◽
2017
◽
Author(s):
W El-Sadda
◽
I Abdel Halim
◽
M El-Ibrashi
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Study
◽
Previously Treated
Download Full-text
A Randomized Phase II Study of Anti-CSF-1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple Negative Breast Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-20-3955
◽
2021
◽
pp. clincanres.3955.2020
Author(s):
Sherko Kuemmel
◽
Mario Campone
◽
Delphine Loirat
◽
Rafael López López
◽
J. Thaddeus Beck
◽
...
Keyword(s):
Breast Cancer
◽
Monoclonal Antibody
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
P5-19-04: Results of a Randomized Phase II Study Demonstrate Benefit of Platinum-Based Regimen in the First-Line Treatment of Triple Negative Breast Cancer (TNBC).
10.1158/0008-5472.sabcs11-p5-19-04
◽
2011
◽
Author(s):
Y Fan
◽
BH Xu
◽
P Yuan
◽
JY Wang
◽
F Ma
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Study
◽
Line Treatment
◽
First Line
◽
Randomized Phase Ii
◽
First Line Treatment
Download Full-text
Final Results of a Randomized Phase II Study Demonstrating Efficacy and Safety of BSI-201, a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor, in Combination with Gemcitabine/Carboplatin (G/C) in Metastatic Triple Negative Breast Cancer (TNBC).
10.1158/0008-5472.sabcs-09-3122
◽
2009
◽
Cited By ~ 16
Author(s):
J. O'Shaughnessy
◽
J. O'Shaughnessy
◽
J. O'Shaughnessy
◽
C. Osborne
◽
C. Osborne
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Study
◽
Parp Inhibitor
◽
Efficacy And Safety
◽
Randomized Phase Ii
Download Full-text
TBCRC030: A randomized, phase II study of preoperative cisplatin versus paclitaxel in patients (pts) with BRCA1/2-proficient triple-negative breast cancer (TNBC)—Evaluating the homologous recombination deficiency (HRD) biomarker.
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.tps1145
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. TPS1145-TPS1145
Author(s):
Erica L. Mayer
◽
Ines Vaz-Luis
◽
Andrea L. Richardson
◽
Charles M. Perou
◽
Nadine M. Tung
◽
...
Keyword(s):
Breast Cancer
◽
Homologous Recombination
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Study
◽
Homologous Recombination Deficiency
◽
Randomized Phase Ii
Download Full-text
Trilaciclib prior to chemotherapy in patients with metastatic triple-negative breast cancer: final efficacy and subgroup analysis from a randomized phase II study
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-21-2272
◽
2021
◽
pp. clincanres.2272.2021
Author(s):
Antoinette R. Tan
◽
Gail S. Wright
◽
Anu R. Thummala
◽
Michael A. Danso
◽
Lazar Popovic
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Subgroup Analysis
◽
Triple Negative
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
Abstract OT2-06-05: A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy
10.1158/1538-7445.sabcs18-ot2-06-05
◽
2019
◽
Cited By ~ 1
Author(s):
HL McArthur
◽
EA Comen
◽
S Solomon
◽
M Rodine
◽
C DiLauro Abaya
◽
...
Keyword(s):
Breast Cancer
◽
Neoadjuvant Chemotherapy
◽
Phase Ii
◽
Triple Negative
◽
Phase Ii Study
◽
Early Stage
◽
Standard Of Care
◽
Operative Care
◽
Randomized Phase Ii
Download Full-text
123MO BARBICAN: A randomized, phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab in women with triple-negative breast cancer
Annals of Oncology
◽
10.1016/j.annonc.2021.08.404
◽
2021
◽
Vol 32
◽
pp. S411-S412
Author(s):
P. Schmid
◽
F.J. Salvador Bofill
◽
B. Bermejo
◽
M. Phillips
◽
D. Wheatley
◽
...
Keyword(s):
Breast Cancer
◽
Neoadjuvant Chemotherapy
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close